Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Guizhi decoction (Guizhi Tang) is a foundational Traditional Chinese Medicine (TCM) formula originally documented in the *Shanghan Lun* (Treatise on Febrile Diseases). It is composed of five primary herbal ingredients: *Ramulus Cinnamomi* (Cinnamon Twig), *Radix Paeoniae Alba* (White Peony Root), *Rhizoma Zingiberis Recens* (Fresh Ginger), *Fructus Ziziphi Jujubae* (Jujube), and *Radix Glycyrrhizae Praeparata* (Honey-fried Licorice Root). While traditionally used for releasing the exterior and harmonizing the Ying and Wei levels, modern research led by institutions such as Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine has focused on its application in rheumatoid arthritis (RA). The decoction exhibits potent anti-inflammatory and immunomodulatory properties, primarily by inhibiting the production of pro-inflammatory cytokines like TNF-α, IL-1β, and IL-6, and modulating the RANKL/OPG signaling pathway to mitigate bone and cartilage destruction. It is also thought to regulate the balance between Th17 and Treg cells, thereby restoring immune homeostasis in autoimmune conditions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on guizhi decoction.